SCHEMBL2471595

SCHEMBL2471595

CCN(CC)C(C)OC(=O)c1ccccc1OC(=O)c1ccccc1OC(=O)c1ccccc1OC(C)=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.57
KDM4E B2RXH2 4/20 0.57
LMNA P02545 1/20 0.57
CYP1A2 P05177 1/20 0.57
CYP2C9 P11712 1/20 0.57
PTGS2 P35354 6/20 0.51
HPGD P15428 3/20 0.48
ALDH1A1 P00352 1/20 0.48
ESR1 P03372 1/20 0.48
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
HMGB1 P09429 1/20 0.48
TSHR P16473 1/20 0.48
GGT1 P19440 1/20 0.48
PTGS1 P23219 1/20 0.48
BLM P54132 1/20 0.48
NAPRT Q6XQN6 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
KMT2A Q03164 2/20 0.45
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2473862 1.00 HSD17B10 (0.57) HSD17B10KDM4ELMNACYP1A2CYP2C9
Hydrochloric Acid SCHEMBL15391747 0.97 PTGS2 (0.53) HSD17B10KDM4ELMNACYP1A2CYP2C9
SCHEMBL2469906 0.97 PTGS2 (0.53) HSD17B10KDM4ELMNACYP1A2CYP2C9
Diplosalsalate SCHEMBL3006517 0.95 KDM4E (0.67) HSD17B10KDM4ELMNACYP1A2CYP2C9
SCHEMBL3807348 0.95 KDM4E (0.67) HSD17B10KDM4ELMNACYP1A2CYP2C9
Aspirin SCHEMBL2472616 0.92 KDM4E (0.62) HSD17B10KDM4ELMNACYP1A2CYP2C9
Aspirin SCHEMBL28641867 0.87 KDM4E (0.55) HSD17B10KDM4ELMNACYP1A2CYP2C9
SCHEMBL3810674 0.87 PTGS2 (0.51) HSD17B10KDM4ELMNACYP1A2CYP2C9
Citric Acid SCHEMBL28465789 0.85 KDM4E (0.44) HSD17B10KDM4ELMNACYP1A2CYP2C9
Hydrochloric Acid SCHEMBL15392163 0.85 PTGS2 (0.49) HSD17B10KDM4ELMNACYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230233516-A1 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS TECHFIELDS PHARMA CO., LTD (CN) 2023-07-27 US disclosed
US-11541029-B2 High penetration compositions and their applications TECHFIELDS PHARMA CO., LTD. (CN) 2023-01-03 US disclosed
US-20110269689-A1 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS PREMIER RESEARCH INTERNATIONAL, LLC 2011-11-03 US disclosed
EP-2370406-A1 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS Yu, Chongxi (US) 2011-10-05 EP disclosed
WO-2010065936-A1 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS YU CHONGXI (US) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269689-A1 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS SLC19A1, HIRA, SLC43A1 HSD17B10 541/4885KDM4E 4307/4885LMNA 1775/4885
US-11541029-B2 High penetration compositions and their applications SLC19A1, HIRA, SLC43A1 HSD17B10 541/4885KDM4E 4307/4885LMNA 1775/4885
US-20230233516-A1 HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS SLC5A7, SLC19A1, SLC43A1 HSD17B10 720/4885KDM4E 2401/4885LMNA 2635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.